Serologic biomarkers of Epstein–Barr virus correlate with TNM classification according to the seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma

Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma

Jin‐Ching Lin, Wenyi Wang, Kuang Yu Chen et al. · New England Journal of Medicine · 2004 · 922 citations · Full text

Medicine, Molecular Biology, Oncology +15

National Comprehensive Cancer Network (NCCN) Head and Neck Cancers NCCN Clinical Practice Guidelines in Oncology . 2010.

Konstantinos Markou, Angelos Nikolaou, Christos Themelis · 2011 · 757 citations

Medicine, Oncology, Surgery +12

Plasma Epstein-Barr Viral Deoxyribonucleic Acid Quantitation Complements Tumor-Node-Metastasis Staging Prognostication in Nasopharyngeal Carcinoma

Sing-Fai Leung, Benny Zee, Edwin P. Hui et al. · Journal of Clinical Oncology · 2006 · 373 citations

Medicine, Oncology, Pathology +17

Comparison of plasma Epstein–Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma

Jian‐Yong Shao, Yuhong Li, Hong‐Yi Gao et al. · Cancer · 2004 · 226 citations · Full text

Life Sciences, Infectious Diseases, Oncology +11

Prospective Study of Tailoring Whole-Body Dual-Modality [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography With Plasma Epstein-Barr Virus DNA for Detecting Distant Metastasis in Endemic Nasopharyngeal Carcinoma at Initial Staging

Lin‐Quan Tang, Qiuyan Chen, Wei Fan et al. · Journal of Clinical Oncology · 2013 · 211 citations · Full text

Medicine, Nuclear Medicine, Oncology +17